Imọ-ẹrọ Synthesis Peptide ti o munadoko Da lori Awọn Ikẹkọ Kemistri-Igbejade Covalent Yiyi

Imọ-ẹrọ Synthesis Peptide ti o munadoko Da lori Awọn Ikẹkọ Kemistri-Igbejade Covalent Yiyi

Background and Challenges

Since the first peptide gly-gly was synthesized in 1901, peptide kolaginni ti koja diẹ ẹ sii ju 100 ọdun ti idagbasoke, and as an important participant in life activities, it has shown great potential in the fields of drug discovery and development, biomaterials, and cosmetics. Traditional peptide synthesis methods are inefficient, costly, and environmentally polluting, which seriously restrict their wide application. The development of efficient, green and economical peptide synthesis technology has become an urgent challenge. Nibi, based on the theoretical foundation of scientific research, we apply the theory to practice and successfully realize the application of catalytic peptide synthesis technology in actual production.


Technological breakthrough

Bifunctional organic small molecule catalyst: Using thiourea-tertiary amine synergistic catalysis, we successfully avoided the involvement of metal and realized the green coupling technology without metal.

  • Unique reaction mechanism: tertiary amine pulls hydrogen to improve the nucleophilicity of amino group, and thiourea’s rigid structure realizes the function of capturing the amino group, thus realizing the fixed-point catalysis.
  • Significantly improved coupling efficiency: the coupling efficiency of a single step under liquid phase conditions has been shortened to 5 iseju, and the coupling efficiency is as high as 99%.
  • Green chemistry technology: water/ionic liquid system replaces DMF to reduce organic waste emission, and the by-product is only water, simple post-processing, and suitable for continuous flow reactor, realizing continuous peptide synthesis on the scale of kilograms.

Ipari

The thiourea-tertiary amine co-catalyzed peptide synthesis technology can rapidly construct peptide libraries for high-throughput screening, significantly shorten the R&D cycle of anticancer and antiviral drugs, support the large-scale production of complex peptides, and promote more peptide drugs to enter into the clinical research. It reduces the use of reagents and solvents, and successfully lowers the cost of peptide synthesis, and can rapidly realize the large-scale synthesis of peptides.

admin Afata

Zejun Peng

Chief Technology Officer; Peptide Synthesis Amoye mojuto ĭrìrĭ: Iṣọkan peptide eka, awọn iyipada amino acid ti kii ṣe adayeba, ati awọn ikole ti cyclic peptides ati stapled peptides.

Igbesiaye:Zejun Peng ni iriri lọpọlọpọ ni kemistri Organic ati iṣelọpọ peptide. O jẹ ọlọgbọn ni ohun elo apapọ ti iṣelọpọ peptide ti o lagbara-alakoso (SPSS) ati iṣelọpọ peptide olomi-alakoso (LPPS), ati pe o jẹ ọlọgbọn ni pataki ni bibori “awọn ọna ṣiṣe ti o nira pupọ-lati-sọpọ” (gẹgẹbi awọn peptides pq ultra-gun, gíga hydrophobic lesese, ati ọpọ disulfide mnu kika). Labẹ olori rẹ, ẹgbẹ naa ti bori awọn igo imọ-ẹrọ ni aṣeyọri ni ọpọlọpọ awọn iyipada pataki (gẹgẹ bi awọn N-methylation, PEGylation, ati aami Fuluorisenti), mimu a kolaginni aseyori oṣuwọn ti lori 98%.

Ti Ṣayẹwo Otitọ & Awọn Itọsọna Olootu
Ayẹwo nipasẹ: Awọn amoye Koko-ọrọ
Ile Wa Whatsapp Awọn iṣẹ Ọja